WE WILL DO OUR BEST

TO INCREASE THE

HEALTHY LIFESPAN

OF MANKIND

text arrow
Current Status
K-Biobank

156K+ Blood Sample, Clinical Data, Lifestyle
Data, Genomic Data, incidence of disease

Other Biobank

The Alzheimer’s Disease Neuroimaging

Initiative(ADNI) (2K+)

UK Biobank (500K+)

The Cancer Genome Atlas(TCGA) (10K +)

confidential

line
img img img
line
To Be Acquired
Data Sources

Multi-Omics Data Genomics, Metabolomics, Proteomics,
Transcriptomics, Microbiome

50K Blood Sample (Rare Disease)

1K Blood Sample (Aging)

COCD Platform

(Clinico-Omics Cohort Database)

Basgenbio has established an optimized environment for precision medicine encompassing diagnosis, prediction,
and treatment by integrating global biobank data centered around the K-Biobank*.
*K-biobank: Clinico-genomic cohort data of 156,000 Korean subjects.

Read more +

BIOBANK

Basgenbio continues to add global biobanks to its self-built COCD* platform, collaborating with various partners to establish new biobanks.

*COCD : Clinico-Omics Cohort Database Read more +
0

Number of Subjects

icon
0 +year

Follow-Up Period

icon
0  vial

Blood Sample Status

icon
0

Number of Subjects
for Genetic Testing

icon

DEEPCTTM

Drug Efficacy Simulation Platform
DEEPCT (DEEP learning-based Clinical Trial) simulates the effects of drugs using COCD*.
It utilizes Mendelian Randomization methods to discover the causes of diseases, recommend optimal drug combinations, identify Drug Responder/Non-Responder groups, and explore new indications for drugs. *COCD : Clinico-Omics Cohort Database

Target Discovery

Read more +

Discovery of disease and drug targets

icon

Drug Combination

Read more +

Recommendation of optimal drug combinations

icon
icon
icon
icon
icon

Drug Response

Read more +

Identification of Drug Responder/Non-Responder markers

Responders
icon
arrow

Non-Responders
icon
arrow

Drug Repurposing

Read more +

Rediscovery of new drug indications

Drug
arrow
  • Indication
  • New Indication
  • New Indication
  • ...

TLBMTM

Time-Labeled Biomarker Discovery and Disease Risk Prediction Solution
Based on COCD*, TLBM (Time-Labeled BioMarker) incorporates time factors for novel biomarker discovery,
providing age-specific prediction of disease risk and improvement methods. *COCD : Clinico-Omics Cohort Database
Read more +

Discovery of
Time-Labeled BioMarker

Discovery of time-labeled biomarkers

icon

Prediction of
Disease Risk by Age

Prediction of disease risk by age group,
and personalized prevention solutions

icon

NEWS
BASGENBIO

  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo